QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Quantum research gets a health mission—and diversity mandate

H.R. 8530 — Quantum for Health Act · Filed by Emilia Sykes (D-OH) · Introduced Apr 27, 2026 · Referred to committee

35%
Transparency
Typical bill: 82%
15/100
Hidden-provision risk
Typical bill: 15/100
Quantum Research Reorientation

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill amends the National Quantum Initiative Act to integrate health and social benefit goals into quantum research programs, add the Department of Health and Human Services to quantum coordination bodies, include nonprofit research organizations alongside universities and industry in advisory committees, and require quantum research centers to develop outreach to underrepresented groups in STEM. It broadens the scope of federal quantum research from pure innovation to include health applications and workforce diversity.

Why we flagged it

The bill's core function is to amend the National Quantum Initiative Act to add health and social benefit mandates, expand governance to include HHS and nonprofits, and require diversity outreach. It is a technical legislative amendment that redirects an existing program rather than creating new authority or spending.

What the text implies

  • Adding HHS to quantum coordination bodies may accelerate quantum computing applications in drug discovery, genomics, and personalized medicine — potentially reducing time-to-market for health innovations but also raising questions about data privacy in health research.
  • Requiring diversity outreach in quantum research centers may increase long-term STEM workforce diversity but could face implementation challenges if funding for outreach is not explicitly appropriated.

The full analysis lists 3 implications of this text.

Who stands to gain

nonprofit research organizations; universities with quantum research programs; pharmaceutical and biotech companies (indirect, via health applications)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record